Bristol-Myers Squibb
$828.5
5335
-$61.49-6.91% Friday 15:41
Statistics
Day High
900
Day Low
788
52W High
1,200
52W Low
700
Volume
10
Avg. Volume
1
Mkt Cap
86.44B
P/E Ratio
-14.06
Dividend Yield
0.24%
Dividend
2
Upcoming
6
AUG
Dividend Ex
3
SEP
Dividend Payment
30
OCT
Dividend Ex
1
DEC
Dividend Payment
29
JAN 25
Dividend Ex
1
MAR 25
Dividend Payment
6
MAY 25
Dividend Ex
3
JUN 25
Dividend Payment
6
AUG 25
Dividend Ex
3
SEP 25
Dividend Payment
Dividends
0.24%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
26JulConfirmed
Expected EPS
1.63
Actual EPS
2.07
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BMYMP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap169.83B
Merck &
MRK
Mkt Cap318.55B
Johnson & Johnson
JNJ
Mkt Cap372.29B
Abbvie
ABBV
Mkt Cap304.29B
GSK
GSK
Mkt Cap81.55B
Novartis
NVS
Mkt Cap232.42B
AMGEN
AMGN
Mkt Cap177.72B
Sanofi
SNY
Mkt Cap128.21B
Roche
RHHBY
Mkt Cap220.72B
Astrazeneca
AZN
Mkt Cap244.04B
About
Pharmaceuticals: Major
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Show more...
CEO
Giovanni Caforio
Country
US
ISIN
US1101222073